Kalamazoo, MI, United States of America

Pil H Lee

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pil H Lee. Retrieved from https://idiyas.com/inventor/pil-h-lee-o35wk6j1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Pil H Lee: Advancing Anthelmintic Research

Introduction

Pil H Lee, an accomplished inventor based in Kalamazoo, Michigan, has made notable contributions to the field of pharmaceutical sciences. With one registered patent to his name, Lee's work focuses on innovative solutions aimed at improving health outcomes.

Latest Patents

Lee's patent is titled "Cycloanthelmintic inhibitors." This invention encompasses novel compounds designed to inhibit the growth of helminths, which are parasitic worms that pose significant health risks. The compounds fall under a specific chemical structure defined in the patent specifications, which provides detailed information regarding the variation of the R groups involved.

Career Highlights

Currently employed at Pharmacia & Upjohn Company, Pil H Lee has been instrumental in advancing pharmaceutical research and development. His work reflects a commitment to addressing critical health challenges through innovative approaches and chemical solutions.

Collaborations

Throughout his career, Lee has collaborated with talented colleagues, including Byung H Lee and William W McWhorter, Jr. These partnerships reflect a collaborative environment at Pharmacia & Upjohn Company, emphasizing the importance of teamwork in driving innovation forward.

Conclusion

Pil H Lee is a distinguished inventor whose work on cycloanthelmintic inhibitors highlights his commitment to advancing medical science. With a strong background in pharmaceutical research, Lee continues to contribute to the development of effective treatments, making a significant impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…